PRJNA482620
Longitudinal genomic study of response to anti-PD-1 immunotherapy in GBM
Through longitudinal tissue imaging, genomic, and transcriptomic analysis (including at the single-cell level), we identified specific molecular alterations in tumors as well as corresponding changes in the immune microenvironment that are associated with response to anti-PD1 immunotherapy of GBM patients.